Cargando…
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
Understanding vaccine-mediated protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 (COVID-19) pandemic. We investigate mRNA-vaccine-induced antibody responses against the reference strain, seven variants, and s...
Autores principales: | Narowski, Tara M., Raphel, Kristin, Adams, Lily E., Huang, Jenny, Vielot, Nadja A., Jadi, Ramesh, de Silva, Aravinda M., Baric, Ralph S., Lafleur, John E., Premkumar, Lakshmanane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769879/ https://www.ncbi.nlm.nih.gov/pubmed/35090596 http://dx.doi.org/10.1016/j.celrep.2022.110336 |
Ejemplares similares
-
In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers
por: Metz, Stefan W., et al.
Publicado: (2017) -
Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in León, Nicaragua
por: González, Fredman, et al.
Publicado: (2021) -
Generation of Mature DENVs via Genetic Modification and Directed Evolution
por: Tse, Longping V., et al.
Publicado: (2022) -
Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
por: Collins, Matthew H., et al.
Publicado: (2017) -
Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period
por: Yu, Esther Dawen, et al.
Publicado: (2022)